Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases

Combination Biologic Therapy in Inflammatory Bowel Disease: Experience from a Tertiary Care Center

(2020) Lukasz Kwapisz et al.   Clinical Gastroenterology and Hepatology

Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease

(2020) Edward Yang et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tu1896 TOFACITINIB IS SAFE AND EFFECTIVE AS MONOTHERAPY OR IN COMBINATION WITH BIOLOGIC THERAPY IN PATIENTS WITH CROHN'S DISEASE

(2020) Kindra D. Clark-Snustad et al.   GASTROENTEROLOGY

The Use of Combination Biologic or Small Molecule Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study

(2020) Kerri Glassner et al.   Journal of Digestive Diseases

Treatment of Ulcerative Colitis and Seronegative Inflammatory Spondyloarthritis With Vedolizumab and Tofacitinib

(2020) Joy A Lee et al.   INFLAMMATORY BOWEL DISEASES

Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s disease

(2019) Ingrid Ordás et al.   GASTROENTEROLOGY

Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

(2018) Catherine Le Berre et al.   Clinical Gastroenterology and Hepatology

Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients

(2015) Edward Shelton et al.   INFLAMMATORY BOWEL DISEASES